LL-37 dosing schedule
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
LL-37 is an antimicrobial peptide that research and protocol sources administer subcutaneously (SubQ). The figures below are a generalized reference from published protocols, not a validated clinical dose.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 100 mcg subcutaneously, once daily | Starting dose |
| Maintenance | 100–300 mcg subcutaneously, once daily | Increase if needed |
| Upper range | up to 400 mcg subcutaneously per day; 4–12 week cycle | Maximum in this schedule |